NOC

Rating neutralAI Memo

Northrop Grumman

As of 2026-10-01/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-10-01 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

neutral

Confidence

medium

Horizon

—

Key catalyst

October 20 third-quarter results • 2026-10-20

Base target: $515 / p=50% prob

Biggest risk

B-21 estimated-cost pressure, weaker Defense and Space operating income in Q2, and Boeing's F/A-XX selection temper the backlog thesis. U.S.-government sales were 84% of Northrop's consolidated 2025 sales, making procurement timing a concentration risk; that figure is not Northrop's share of government spending [#10-K-2026-01-27] [#REL-c253007c-2bc8-4eeb-a3c2-223f4ebfab02].

Invalidation

Break below $390 or thesis failure.

What would change my mind?

Q2 sales rose 5% year over year to $10.9 billion, net awards reached $20 billion, backlog hit $105 billion, and management raised 2026 sales and MTM-adjusted EPS guidance. B-21 capacity and Sentinel testing offer identifiable longer-term milestones [#SEC-8K-2026-07-21].

Research note

Recommendation

neutral

Confidence

medium

As of

2026-10-01

Base target

$515

p=50%

Bull target

$585

p=30%

Bear target

$390

p=20%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Navy F/A-XX award to Boeing
B-21 production-rate expansion
Sentinel flight-test milestone

BearKey bullets

B-21 fixed-price production costs and estimate-at-completion adjustments may offset higher output [#REL-ba3e9507-3559-4d89-ab39-b760e0ffe878].
Government procurement concentration, contract timing and backlog conversion can create results volatility [#REL-c253007c-2bc8-4eeb-a3c2-223f4ebfab02].
Relationship extraction has failed or pending jobs and continuity reviews; absence of other links is not evidence of no exposure.

WatchKey bullets

October 20 third-quarter results

Summary

High-level snapshot

Recommendation

neutral

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $515 (p=50%)

Target spread vs base: +14% / -24%

Scenario probabilities

Bull Target: $585 (p=30%)Base Target: $515 (p=50%)Bear Target: $390 (p=20%)

Commentary

The deterministic prior is modestly positive, supported by Q2 awards, backlog and raised sales/EPS guidance, but the confirmed F/A-XX award to Boeing adds a fresh negative headline. The packet supplies no verified post-award NOC price reaction, analyst revisions or sufficient social/options data; the numerical sentiment fields other than headline buzz should not be read as observed measurements. This remains a monitoring view ahead of October 20 results.

As of 2026-10-01 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Navy F/A-XX award to Boeing
B-21 production-rate expansion
Sentinel flight-test milestone

Scenarios

Bull Target (Scenario probability)

$585 / p=30% prob

Base Target (Scenario probability)

$515 / p=50% prob

Bear Target (Scenario probability)

$390 / p=20% prob

Analysis 2026-10-01 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

-0.15

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-10-20
October 20 third-quarter results
Northrop scheduled Q3 results before the October 20 market open. The test is whether awards, backlog conversion, segment margins and cash flow sustain the Q2 release's $105 billion backlog and raised 2026 sales guidance of $43.75 billion–$44.25 billion. The release reaffirmed operating-income and adjusted-free-cash-flow guidance [#PR-EARNINGS-2026-09-17] [#SEC-8K-2026-07-21]. Company earnings date
Prob 75.00% • Move 5.00% • Priced-in 45.00%

Short-term Catalysts

Next few weeks

Navy F/A-XX award to Boeing
2026-09-29
Boeing announced its September 29 selection for the Navy's F/A-XX fighter. Northrop's 2025 filing identifies Boeing as a competitor, but neither source quantifies forgone Northrop revenue; treat the award as a competitive setback, not a booked-contract cancellation [#REL-fcfa4066-97d4-4009-b168-4b8ea36f480e]. Boeing announcement
Prob 90% • Move -4% • Priced-in 70%

Long-term Catalysts

Months to a year

B-21 production-rate expansion
2027-12-31
The U.S. Air Force agreement calls for expanded B-21 capacity and production rate. The disclosed contract baseline is 21 aircraft, not deliveries to date; a $157 million unfavorable adjustment on the first four low-rate production lots underscores margin risk. Conversion and profitability remain to be demonstrated [#10-Q-2026-07-21] [#REL-ba3e9507-3559-4d89-ab39-b760e0ffe878] [#REL-f9666c7b-c921-4ca0-b3ea-ff5aa3534b64]. SEC filing
Prob 60% • Move 7% • Priced-in 50%
Sentinel flight-test milestone
2027-12-31
Northrop reported completed inert-missile vertical assembly and a flight-test critical design review, with flight testing targeted for 2027. Its current U.S. Air Force contract covers engineering and manufacturing development; later production and deployment phases are not established as awarded [#REL-7d13d65c-69af-4de1-9f92-d1fbf31b9ef5] [#PR-2026-09-14]. The expected date denotes the disclosed year, not an announced test day. Company update
Prob 60% • Move 6% • Priced-in 40%

Risks

B-21 fixed-price production costs and estimate-at-completion adjustments may offset higher output [#REL-ba3e9507-3559-4d89-ab39-b760e0ffe878].
Government procurement concentration, contract timing and backlog conversion can create results volatility [#REL-c253007c-2bc8-4eeb-a3c2-223f4ebfab02].
Relationship extraction has failed or pending jobs and continuity reviews; absence of other links is not evidence of no exposure.
Sentinel execution and timing remain uncertain; the currently cited contract is for development, while later phases require pricing and negotiation [#REL-7d13d65c-69af-4de1-9f92-d1fbf31b9ef5].
The Navy's F/A-XX selection of Boeing is a competitive loss, but the packet does not quantify a Northrop earnings impact. Boeing announcement

Peers

Symbol	Summary
BA	Direct aerospace-defense competitor and F/A-XX awardee; commercial-aircraft exposure makes whole-company multiples a poor standalone NOC benchmark [#REL-fcfa4066-97d4-4009-b168-4b8ea36f480e].
LMT	Direct defense-program comparator, though program mix and margins differ; more relevant than the packet's broad industrial candidates.
RTX	Direct defense-market comparator, but commercial aerospace exposure limits valuation comparability.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-10-01

Loading AI feed…

Symbol

Summary

Direct aerospace-defense competitor and F/A-XX awardee; commercial-aircraft exposure makes whole-company multiples a poor standalone NOC benchmark [#REL-fcfa4066-97d4-4009-b168-4b8ea36f480e].

LMT

Direct defense-program comparator, though program mix and margins differ; more relevant than the packet's broad industrial candidates.

RTX

Direct defense-market comparator, but commercial aerospace exposure limits valuation comparability.